Target intelligence / Profile preview

Ocular surface tissue

Molecular classification
Other (tissue/organ system, not a single molecule or receptor)
01

Overview

Ocular surface tissue refers collectively to the anatomical structures forming the exposed front part of the eye. This includes primarily the **cornea**, **conjunctiva**, **limbus**, and is functionally supported by associated glands such as the lacrimal gland and meibomian glands. The ocular surface is covered by a specialized epithelial layer overlaid with a tear film that provides essential hydration, lubrication, optical clarity, and immune protection. The glycocalyx—a carbohydrate-rich layer on epithelial cells—plays a critical role in maintaining barrier integrity against pathogens while supporting cell signaling functions important for tissue health. Disruption or alteration of these tissues or their protective layers can lead to various ocular diseases including dry eye syndrome, infections, allergic reactions, and complications from systemic conditions like diabetes or graft-versus-host disease. While crucial for vision health and an important site for drug delivery in ophthalmology research, "ocular surface tissue" itself is not a molecular therapeutic target but rather an anatomical region composed of multiple cell types with diverse molecular targets within it[2][4][7]. **Note:** "Ocular surface tissue" is not a specific molecule/receptor but rather an anatomical term encompassing several tissues; therefore it does not fit standard definitions used for drug targets such as receptors or enzymes. If you are seeking information about specific molecular targets within this region (such as mucins or membrane proteins), please specify further so more precise data can be provided.

Other names
Ocular surfaceOcular surface microenvironmentSurface of the eyeAnterior ocular mucosa
02

Biological functions

Barrier protection against pathogens[4]Maintenance of hydration and lubrication[2][7]Immune defense and homeostasis[4][6]Support for vision via light entrance and refraction[7]
03

Disease associations

Inflammation (e.g., dry eye disease, allergies)[2]Infection (bacterial, viral, fungal)[2][4]Autoimmune/systemic diseases (e.g., Graft-versus-host disease, diabetes mellitus)[2]
04

Safety considerations

Susceptibility to inflammation and infection due to barrier disruption[2][4]

Beyond the preview

Go deeper on Ocular surface tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular surface tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call